Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne

Clinical trial NCT00975143 · COMPLETED

Trial details

NCT number: NCT00975143
Sponsor: Cipher Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Severe Nodular Acne

Start date: 2009-09-01
Primary completion: 2011-05-01
Enrollment: 925

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.